What are Travere Therapeutics, Inc.'s profit margins?

Travere Therapeutics, Inc. (TVTX) runs a 98.6% gross margin and a -10.6% operating margin, with a -20.3% net margin.

Where do Travere Therapeutics, Inc.'s ratios come from?

Every ratio is computed from Travere Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Travere Therapeutics, Inc. TVTX Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Profitability
Gross margin	97.9%+1.2pp	96.7%+4.6pp	92.1%-2.2pp	94.4%—
Operating margin	-12.8%+126pp	-138.9%+128pp	-267.2%+24.9pp	-292.2%—
EBITDA margin	-0.4%+120pp	-120.2%+121pp	-240.7%+31.8pp	-272.5%—
Returns
Return on invested capital	-96.2%+151pp	-247.2%+176pp	-423.6%-77.6pp	-346%-226pp
Efficiency
Asset turnover	0.8×+0.5×	0.3×+0.1×	0.2×0.0×	0.2×—
Inventory turnover	0.3×+0.1×	0.2×—	——	——
Liquidity
Current ratio	2.7×+0.7×	2.1×-1.4×	3.5×0.0×	3.4×-1.3×
Quick ratio	2.5×+0.6×	1.9×-1.4×	3.3×-0.1×	3.4×-1.2×
Cash ratio	0.6×+0.3×	0.3×0.0×	0.3×-0.1×	0.4×-0.9×
Leverage
Debt-to-equity	0.1×-1.4×	1.5×+1.4×	0.1×-0.6×	0.7×+0.6×
Debt-to-assets	0×-0.1×	0.2×+0.1×	0×0.0×	0×0.0×
Interest coverage	-5.8×+23.1×	-29×+39.9×	-68.9×-39.4×	-29.5×—
Per Share
Book value per share	$1.29+71.9%	$0.75-72.3%	$2.70+302%	$0.67-86.7%
Valuation
Market capitalization	$3.42B+125%	$1.52B+121%	$687.51M-49.1%	$1.35B-31.1%
Enterprise value	$3.34B+116%	$1.55B+136%	$656.85M-50.3%	$1.32B-27.8%
Price / sales	7×+0.5×	6.5×+1.8×	4.7×-7.6×	12.3×—
Price / book	29.8×+4.1×	25.7×+22.2×	3.4×-28.1×	31.5×+25.0×
EV / sales	6.8×+0.2×	6.6×+2.1×	4.5×-7.5×	12.1×—

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Travere Therapeutics, Inc.'s profit margins?: Travere Therapeutics, Inc. (TVTX) runs a 98.6% gross margin and a -10.6% operating margin, with a -20.3% net margin.
Where do Travere Therapeutics, Inc.'s ratios come from?: Every ratio is computed from Travere Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.